In particular, the administration of IL 17-A, a cytokine crucial in psoriasis pathogenesis in animal models, could activate the pathway of the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) and p38mitogen-activated protein kinase (MAPK) [46]. The gene discussed is NFKB1; the disease is psoriasis.